Purpose To evaluate the imaging characteristics of a cohort of patients with ocular adnexal lymphoproliferative disease (OALD). Methods A noncomparative retrospective review between 1992 and 1995 and prospective study from 1995 to 2005 of the clinical, imaging and treatment of 105 patients presenting to tertiary orbital referral centre presenting with OALD. Results One hundred and five patients (mean age 61 years, range 11-90 years) with equal gender distribution were included. Fifty-three were primary and 52 were secondary. Computed tomography (CT) usually showed a well-circumscribed lesion of greater than brain density, moulding to adjacent tissues with moderate enhancement. Aggressive histology was associated with bone destruction, while moulding was associated with indolent histology (Po0.005). MRI in OALD showed intermediate signal intensity on T1-and T2-weighted images and moderate enhancement with gadolinium. Gallium scanning sensitivity to detect ocular adnexal disease was 25 and 57% for systemic involvement. Positron emission tomography (PET) upstaged (71%) of patients with systemic lymphoproliferative involvement, having a higher sensitivity than CT in detecting distant disease (86 vs 72%). Conclusions CT and/or MRI are essential in the evaluation of OALD and can be used to establish that an orbital lesion may be lymphoprolifetaive in nature. Further, these imaging modalities may predict the behaviour of the lymphoma in certain cases. Gallium scanning provides no additional information to CT and does not influence patient treatment. PET represents an important addition to the assessment of OALD with real impact on patient management.
Introduction
The computed tomographic (CT) features of ocular adnexal lymphoproliferative disease (OALD) have been described in the past. [1] [2] [3] [4] [5] [6] Magnetic resonance imaging (MRI) studies have also been reported. [5] [6] [7] However, the imaging features of ocular adnexal lymphoproliferative disease have not been well described with regards to recent advances in imaging techniques. Further, there is no current protocol for imaging studies in patients with this disorder. For this reason, we undertook a study to evaluate the imaging characteristics of a cohort of patients with OALD to propose a protocol for initial and ongoing imaging studies.
Materials and methods
One hundred and five cases of OALD were seen in a tertiary orbital referral centre from 1992 to 2005. Data from 1992 to 1995 were collected retrospectively in 1995, at which time a spreadsheet was developed to allow prospective information collection. Data were then collected prospectively from 1995 until 2005. Open surgical biopsy was performed to confirm the diagnosis in all cases. Histomorphologic, immunophenotypic, and molecular genetic findings were used to establish the diagnosis. Flow cytometry, PCR, and cytogenetics generally confirmed the presumed histomorphological diagnosis and established evidence of monoclonality in some equivocal patients. Cases were classified according to the WHO modification of the REAL classification. [8] [9] [10] Received: 12 Anatomical site was divided into orbital, conjunctival, lacrimal sac, and eyelid lesions, based on clinical, imaging, and intra-operative findings, as previously defined. 11 The CT scanning of the ocular adnexae was performed using axial and direct coronal 2-mm contiguous slice imaging, with administration of intravenous contrast. The images were evaluated by a single observer (TJS) for location, circumscription, density, enhancement with contrast media, moulding to adjacent structures, calcification, tissue invasion, and bone destruction. MRI characteristics studied included appearance on T1 and T2 weighted images in relation to the extra ocular muscles, as well as degree of enhancement with the paramagnetic substance gadolinium diethylene-triamine penta-acetic acid (gadolinium). The sensitivity of Gallium and Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG-PET) scanning was also assessed for detection of both orbital and systemic disease at staging and compared to CT-scan. Patients were referred for systemic oncological workup and treatment planning. This included general clinical examination, CT of neck, chest, abdomen and pelvis, full blood count, serum lactate dehydrogenase, and electrophoresis, bone marrow trephination and additional biochemical analysis or endoscopic gastro-intestinal imaging depending on the case.
Statistical methods
For statistical purposes patients with indolent histological types were grouped together. These included the MALT, follicular, chronic lymphocytic (CLL), lymphoplasmacytic, acute lymphoblastic (ALL), lymphoblastic lymphomas, plasmcytomas, and reactive lymphoid hyperplasia (RLH). T-cell and NK/T-cell lesions, diffuse large B-cell lymphoma (DLBCL) and mantle cell lesions were grouped into the aggressive category. The patient's findings on CT were compared depending on the histologic type using the chi-square test to compare proportions between groups (SPSS software, version 11.0.2; SPSS Inc., Chicago, IL).
Results
One hundred and five patients, with a mean age at presentation of 61 years (range 11-90 years), were seen during the period of the study. The gender distribution in this cohort was uniform with 52 females and 53 males. There was equal presentation of primary disease limited to the ocular adnexae vs having systemic involvement (53 cases primary/52 cases systemic).
The orbit was the preferred site of involvement (78%), with the lacrimal gland the most commonly affected (33%), followed by the extraconal space (20%) and the extra ocular muscles (15%). OALD rarely located to the intraconal space and/or the optic nerve (Table 1) .
CT imaging of the orbits was performed in 87 cases. Most of these patients presented with a wellcircumscribed lesion that tended to mould to adjacent tissues, of greater density than brain (Figure 1a and b). In Figure 1 (a, b) Axial and coronal orbital CT scan showing a classical appearance of an indolent OALD in a patient with follicular lymphoma, presenting with an extraconal, homogeneous, well-defined, noncalcified lesion that moulds to the left globe, without producing ocular indentation, bone destruction or invasion into neighbouring tissues. The mass has greater density than the brain.
half of the cases it showed moderate enhancement with contrast media. Calcification and bone destruction were rare and 25% showed invasion into neighbouring tissues ( (Table 3 )(Figure 4a-c). Nine patients did not have either CT or MRI studies. These cases had discrete conjunctival, superficial eyelid, or lacrimal sac involvement found only during surgery.
Gallium scanning was performed in 12 cases, of whom seven presented with secondary systemic involvement ( Figure 5 ). At staging, the sensitivity of gallium imaging to detect ocular adnexal disease was 25% (3/12 cases) and 57% for the detection of systemic involvement (4/7 cases). In none of these cases did gallium scanning provide additional information to CT, having no impact on patient management. Imaging in ocular adnexal lymphoma TJ Sullivan and AA Valenzuela
Positron emission tomography was performed in fourteen patients at staging ( Figure 6 ). Seven cases were primary orbital lymphomas and from the remaining seven, six presented with the systemic disease simultaneously to the ocular adnexal involvement. In this last group with orbital and systemic lymphomatous 
Discussion
Early reports of the imaging features of OALD have given rise to classic descriptions which are still current today. [1] [2] [3] [4] [5] [6] Yeo et al studied 26 patients and found that lesions moulded or plastered themselves to pre-existing orbital structures, such as the globe, extraocular muscles, lacrimal gland, or bony orbital walls, without eroding bone or enlarging the orbit. Where lymphoid tumours abutted orbital fat they adopted a streaky profile, presumably due to irregular infiltration reflecting involvement of microfascial structural elements. 1 Henderson described homogenous tumours of relatively high density with a soft putty-like appearance that showed mild contrast enhancement. 12 Shields described oblong tumours, oval in shape that often followed the fascial planes of the orbit with a pancake contour. 13 The difficulty in distinguishing between benign and malignant lymphoid proliferations and between inflammatory and lymphoproliferative lesions has also been stressed. [4] [5] [6] We also found that CT scans most commonly demonstrated lesions that were homogenous, well circumscribed, of greater than brain density, moderately enhancing and moulded to adjacent orbital structures, as per these previous classic descriptions. (Figure 1a and b) There was a statistically significant association between indolent histology and the CT appearance of moulding. Nonetheless, we also saw atypical lesions that showed an infiltrative pattern, were inhomogeneous, or had calcification or bone changes (Figures 2a and b, 3) . These atypical imaging appearances occurred across all histological groups but were more highly represented by the diffuse large B-cell (DLBCL) and T-cell lymphomas, with a statistically significant association between bone destruction and aggressive histology. Interestingly, the three mantle cell tumours in our series, despite their aggressive behaviour, did not show tissue invasion or bone destruction but showed the moulding characteristics associated with indolent lesions. Similar to others, we were unable to distinguish reactive lesions from true lymphoma. 1, 6 MRI studies have also been reported, with some authors stating that T2-weighted images were helpful because of lesion hyperintensity. 14, 15 Other authors found variable lesion intensity on T2 images. 6 We found that both T1-and T2-weighted images were isointense to extraocular muscle and showed moderate enhancement with gadolinium in the majority of cases. 5, 6 (Table 3 ) (Figure 4a -c) These findings were nonspecific and similar to those found by others. 5, 7 We consider that both CT and MRI provide useful information about disease in the ocular adnexea but that CT offers some advantages in atypical cases, which may show bone changes. MRI provides complementary information and demonstrates extension into adjacent structures such as the CNS and sinuses very well.
Systemic imaging screening with Gallium ( 67 Ga) and FDG-PET were useful as noninvasive methods for establishing the stage of OALD. FDG-PET is currently our preferred method for systemic evaluation, with greater sensitivity than either Gallium or CT. Gallium scanning has been largely superseded by FDG-PET. The mechanism of intracellular accumulation of 67 Ga in lymphoproliferative disease is still a controversy, possibly due to preferential uptake of transferrin by malignant cells, altered plasma membrane function and/or slow clearance from lysosyme-like granules in tumour cells. [16] [17] [18] [19] [20] [21] The cooperative studies in the 1970s reported patient and site sensitivity of approximately 65% for the detection of non-Hodkin's lymphoma. 22, 23 Improved technology and the use of single photon emission computed tomography (SPECT) increase the accuracy of gallium scanning at initial staging from 78% with planar imaging to 85% with the use of SPECT. [24] [25] [26] [27] Unfortunately, in our study, Gallium imaging found disease only in 50% of the cases, providing no additional information to CT/MRI and did not change clinical management in any case. Gallium scanning has been gradually replaced in our management by FDG-PET since 2002.
FDG-PET uptake by malignant cells is also an expression of altered metabolism occurring during malignant transformation, in which glycolysis becomes the main metabolic pathway. 28 With increased numbers of glucose transporters on the tumour cell surface and the enhanced activity of some glycolytic enzymes, there is an increased uptake by malignant cells as compared with normal tissues. Inside the cell, FDG is converted in FDG-6-phosphate, which is not a suitable substrate for further glycolysis, and is dephosphorylated at a decreased rate. FDG is, therefore, trapped intracellularly in the viable tumour. The intracellular accumulation of FDG reflects the glycolytic metabolic rate in malignant cells and is useful for imaging cancerous tissues. 28, 29 High avidity of FDG has been described for most types of lymphoma. [30] [31] [32] [33] [34] [35] In our study, FDG-PET presented a higher sensitivity in detecting systemic disease (86%) in comparison to gallium scanning (57%) and CT-scan imaging (72%). 36 The sensitivity to detect disease affecting the ocular adnexae was higher than gallium scanning (42 vs 25%), but significantly lower than CTscan (42 vs 79%). FDG-PET changed the management in 71% of the secondary OALD patients, detecting viable sites of active systemic disease, providing whole body screening, and guiding specific diagnostic studies (directing MRI-CT, expert assessment, bone marrow biopsy, etc) in selected cases. We consider that its ability to find systemic extra-nodal lymphomatous sites, not detected with traditional imaging, offers valuable information to refine and guide the management of OALD patients. 36 However, this test also has limitations due to multiple factors, such as: the relatively small tumour volume of adnexal lesions, the large amount of background physiological activity in the orbits from the extra-ocular muscles and the proximity to the intense physiological uptake from the brain. 36, 37 The development of simultaneous PET-CT scanning provides combined images of morphology and function in the same study, providing useful information for the optimal management in these patients. 38 Our approach for the imaging in patients with OALD is to request an axial and coronal head and orbit CT-scan with contrast prior to the biopsy of any case in which a lymphoproliferative disease is suspected, in an attempt to define the location, extension, tissue invasion, bone changes and intrinsic features of the lesion (homogeneity, moulding, enhancement, etc). MRI may help in a number of situations, such as cases, which present a convex contour in the superior orbit on CT which might be due to lymphoma or due to a subperositeral haematoma. The different signal characteristics of blood breakdown products allow differentiation. CNS and sinus involvement can also be assessed with MRI.
After histopathological confirmation, a systemic workup by an oncologist should ideally include a whole body FDG-PET and CT of the neck-chest-abdomen and pelvis at staging, to detect possible systemic involvement and guide specific additional studies. We follow our patients with a new head and orbit CT-scan or MRI after the treatment is completed, usually 4-6 months after the diagnosis. Regarding the possibility of local adnexal recurrence, we continue requesting orbital CT-scans 6 monthly for the first year, independent on the histological type. The imaging studies are then performed yearly for 2 years. Following that images are requested if there is any clinical suggestion of local recurrence. If a relapse is suspected at any stage, CT or MRI and FDG-PET is requested and further oncological staging is performed as previously described. As a result of the known incidence of late local and systemic recurrence and mortality, we believe that these patients should be followed for life, in conjunction with the treating oncologist and the family practitioner.
11,39 When CT-PET becomes more widely available, this may become the preferred technique, considering this combines functional and anatomical information simultaneously.
